ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

Recruiting

Phase 1

Phase 2

ET140203ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

Sponsor:

Eureka Therapeutics Inc.

Code:

NCT04634357

Conditions

Hepatoblastoma

Hepatocellular Carcinoma (HCC)

Liver Neoplasms

Metastatic Liver Cancer

Liver Cancer

Eligibility Criteria

Sex: All

Age: 1 - 21

Healthy Volunteers: Not accepted

Interventions

ET140203 T Cells

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Eureka Therapeutics Inc. on 2025-04-09.